Mackenzie Financial
CDNA icon

Mackenzie Financial’s CareDx CDNA Stock Holding History

Mackenzie Financial’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,001
Closed -$639K – 1724
2025
Q1 		$639K Buy
36,001
+6,515
+22% +$140K ﹤0.01% 1119
2024
Q4 		$631K Buy
+29,486
New +$717K ﹤0.01% 1077
2022
Q1 		– Sell
-5,626
Closed -$256K – 1423
2021
Q4 		$256K Buy
5,626
+653
+13% +$34.1K ﹤0.01% 1224
2021
Q3 		$315K Buy
4,973
+1,410
+40% +$107K ﹤0.01% 1117
2021
Q2 		$326K Buy
+3,563
New +$283K ﹤0.01% 1052

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return